Optical biometry is the most precise

Article

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Dr Peiyang Shen et al., Division of Preventive Ophthalmology, Zhongshan Ophthalmic Center, Guangzhou, China, compiled a comparative evaluation on optical biometry (OLCR), partial coherence interferometry (PCI) applanation ultrasound biometry in highly myopic eyes.

Biometric measurements were recorded in patients with a spherical equivalence (SE) of -6.00 D or higher and an axial length (AL) of more than 25.0 mm. OLCRS was used to obtain AL and anterior chamber depth (ACD) and compared to the results obtained using PCI and applanation A-scan ultrasound. Bland-Altman analyses were used to evaluate repeatability.

The coefficient of variations (CoVs) for OLCR, PCI and applanation ultrasound were 0.06%, 0.07%, and 0.20%, respectively. ACD was recorded at 0.29 mm, 0.53 mm and 0.51 mm, respectively. Mean radius of corneal curvature was the most similar between OLCR and PCI, with a limit of agreement of 0.12 mm.

The AL and ACD measurements obtained by optical biometry were more precise and repeatable, compared to measurements obtained from applanation biometry.

The abstract can be viewed in the latest issue of the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.